Evaluation of [18F] PBR111 and PET as a Marker of Inflammation in Subjects With Neurological Conditions
NCT01209156
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class
Conditions
Alzheimer Disease
Interventions
DRUG:
[18F] PBR111
Sponsor
Institute for Neurodegenerative Disorders